In fact, HLA class I and class II genotypes have been shown to influence mutational events in cancers in a Darwinian fashion, being complementary to each other in establishing the patterns of immune escape from both CD8+ and CD4+ T-cell responses (44, 45). This evidence concerns the gene CD4 and cancer.